Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
Panic Disorder01:27

Panic Disorder

Panic disorder is an anxiety disorder characterized by recurrent and sudden minutes-long episodes of intense fear, known as panic attacks. These attacks may feel like heart attacks and often happen without warning or a specific cause. They can include symptoms such as rapid heart rate, shortness of breath, chest pain, trembling, sweating, dizziness, and a sense of helplessness. During a panic attack, individuals may feel as though they are experiencing a heart attack or are in a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunopsychiatry: current concepts and future directions.

Immunologic research·2026
Same author

Prognostic implications of social anxiety comorbidity in major depressive disorder. Evidence from three large samples with adult and older patients.

Journal of affective disorders·2026
Same author

Astrocyte-mediated hippocampal damage in the pathogenesis of dysexecutive syndrome following COVID-19: A narrative review.

Journal of psychiatric research·2026
Same author

Impact of selected second and third generation antipsychotics on cognitive dysfunction in schizophrenia-spectrum disorders. Systematic review and network meta-analysis.

International clinical psychopharmacology·2025
Same author

The quantum-classical complexity of consciousness and orchestrated objective reduction.

Frontiers in human neuroscience·2025
Same author

Specific symptomatology profile associated with treatment resistant depression: A multicentric study from the Group for the Study of Resistant Depression with a focus on sex.

Journal of affective disorders·2025
Same journal

Fatal Rhinocerebral Mucormycosis and <i>Aspergillus flavus</i> Coinfection Complicated by Internal Carotid Artery Arteritis: A Case Report.

Case reports in medicine·2026
Same journal

A Case of Strabismus in a Patient With Psoriasis.

Case reports in medicine·2026
Same journal

Acute Right Ventricular Failure Triggered by Excessive Fluid Resuscitation in Septic Shock.

Case reports in medicine·2026
Same journal

Tourniquet-Induced Atypical Lower Back Pain Under Spinal Anesthesia: A Case Report and Mechanistic Exploration of Referred Pain.

Case reports in medicine·2026
Same journal

Paroxysmal Atrial Tachycardia With Atrioventricular Block: A Report of Two Cases.

Case reports in medicine·2026
Same journal

Incidental Tentorial Cerebelli Hypoplasia: A Case Report and Comprehensive Literature Review of Its Clinical and Imaging Characteristics.

Case reports in medicine·2026
See all related articles

Related Experiment Video

Updated: Jun 10, 2026

Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale
07:35

Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale

Published on: July 8, 2025

Valproate in conversion disorder: a case report.

Antonino Messina1, Anna Maria Fogliani

  • 1Medical and Surgical Specialties, School of Psychiatry, Faculty of Medicine and Surgery, University of Catania, Via S. Sofia, 78, 95123 Catania, Italy.

Case Reports in Medicine
|July 31, 2010
PubMed
Summary
This summary is machine-generated.

Valproate extended release (ER) effectively treated conversion disorder in a case study. This study highlights a novel pharmacological approach for managing conversion disorder symptoms.

More Related Videos

Transauricular Vagus Nerve Stimulation and Electroencephalographic Assessment in Disorders of Consciousness
04:04

Transauricular Vagus Nerve Stimulation and Electroencephalographic Assessment in Disorders of Consciousness

Published on: July 11, 2025

Related Experiment Videos

Last Updated: Jun 10, 2026

Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale
07:35

Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale

Published on: July 8, 2025

Transauricular Vagus Nerve Stimulation and Electroencephalographic Assessment in Disorders of Consciousness
04:04

Transauricular Vagus Nerve Stimulation and Electroencephalographic Assessment in Disorders of Consciousness

Published on: July 11, 2025

Area of Science:

  • Neurology
  • Psychiatry

Background:

  • Limited research exists on pharmacological treatments for conversion disorder.
  • No prior studies have investigated Valproate extended release (ER) for conversion disorder.

Observation:

  • A case of an Italian woman diagnosed with conversion disorder was observed.
  • The patient presented with symptoms indicative of conversion disorder.

Findings:

  • Treatment with Valproate ER resulted in effective and rapid symptom resolution.
  • The patient experienced significant improvement following the administration of Valproate ER.

Implications:

  • Valproate ER may represent a viable therapeutic option for conversion disorder.
  • Further research is warranted to explore the efficacy of Valproate ER in larger patient cohorts.